125 related articles for article (PubMed ID: 21474938)
1. Role of phosphoinositide-specific phospholipase C η2 in isolated and syndromic mental retardation.
Lo Vasco VR
Eur Neurol; 2011; 65(5):264-9. PubMed ID: 21474938
[TBL] [Abstract][Full Text] [Related]
2. 1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours.
Lo Vasco VR
J Neurooncol; 2011 Jul; 103(3):409-16. PubMed ID: 20878447
[TBL] [Abstract][Full Text] [Related]
3. SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females.
Radio FC; Pang K; Ciolfi A; Levy MA; Hernández-García A; Pedace L; Pantaleoni F; Liu Z; de Boer E; Jackson A; Bruselles A; McConkey H; Stellacci E; Lo Cicero S; Motta M; Carrozzo R; Dentici ML; McWalter K; Desai M; Monaghan KG; Telegrafi A; Philippe C; Vitobello A; Au M; Grand K; Sanchez-Lara PA; Baez J; Lindstrom K; Kulch P; Sebastian J; Madan-Khetarpal S; Roadhouse C; MacKenzie JJ; Monteleone B; Saunders CJ; Jean Cuevas JK; Cross L; Zhou D; Hartley T; Sawyer SL; Monteiro FP; Secches TV; Kok F; Schultz-Rogers LE; Macke EL; Morava E; Klee EW; Kemppainen J; Iascone M; Selicorni A; Tenconi R; Amor DJ; Pais L; Gallacher L; Turnpenny PD; Stals K; Ellard S; Cabet S; Lesca G; Pascal J; Steindl K; Ravid S; Weiss K; Castle AMR; Carter MT; Kalsner L; de Vries BBA; van Bon BW; Wevers MR; Pfundt R; Stegmann APA; Kerr B; Kingston HM; Chandler KE; Sheehan W; Elias AF; Shinde DN; Towne MC; Robin NH; Goodloe D; Vanderver A; Sherbini O; Bluske K; Hagelstrom RT; Zanus C; Faletra F; Musante L; Kurtz-Nelson EC; Earl RK; Anderlid BM; Morin G; van Slegtenhorst M; Diderich KEM; Brooks AS; Gribnau J; Boers RG; Finestra TR; Carter LB; Rauch A; Gasparini P; Boycott KM; Barakat TS; Graham JM; Faivre L; Banka S; Wang T; Eichler EE; Priolo M; Dallapiccola B; Vissers LELM; Sadikovic B; Scott DA; Holder JL; Tartaglia M
Am J Hum Genet; 2021 Mar; 108(3):502-516. PubMed ID: 33596411
[TBL] [Abstract][Full Text] [Related]
4. A new 1p36.13-1p36.12 microdeletion syndrome characterized by learning disability, behavioral abnormalities, and ptosis.
Aagaard Nolting L; Brasch-Andersen C; Cox H; Kanani F; Parker M; Fry AE; Loddo S; Novelli A; Dentici ML; Joss S; Jørgensen JP; Fagerberg CR
Clin Genet; 2020 Jun; 97(6):927-932. PubMed ID: 32170730
[TBL] [Abstract][Full Text] [Related]
5. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
[TBL] [Abstract][Full Text] [Related]
6. 1p36 deletion syndrome associated with Prader-Willi-like phenotype.
Tsuyusaki Y; Yoshihashi H; Furuya N; Adachi M; Osaka H; Yamamoto K; Kurosawa K
Pediatr Int; 2010 Aug; 52(4):547-50. PubMed ID: 20113418
[TBL] [Abstract][Full Text] [Related]
7. Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions.
Ballif BC; Yu W; Shaw CA; Kashork CD; Shaffer LG
Hum Mol Genet; 2003 Sep; 12(17):2153-65. PubMed ID: 12915474
[TBL] [Abstract][Full Text] [Related]
8. Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome.
Kurosawa K; Kawame H; Okamoto N; Ochiai Y; Akatsuka A; Kobayashi M; Shimohira M; Mizuno S; Wada K; Fukushima Y; Kawawaki H; Yamamoto T; Masuno M; Imaizumi K; Kuroki Y
Brain Dev; 2005 Aug; 27(5):378-82. PubMed ID: 16023556
[TBL] [Abstract][Full Text] [Related]
9. Contiguous ∼16 Mb 1p36 deletion: Dominant features of classical distal 1p36 monosomy with haplo-lethality.
Nicoulaz A; Rubi F; Lieder L; Wolf R; Goeggel-Simonetti B; Steinlin M; Wiest R; Bonel HM; Schaller A; Gallati S; Conrad B
Am J Med Genet A; 2011 Aug; 155A(8):1964-8. PubMed ID: 21739569
[TBL] [Abstract][Full Text] [Related]
10. Further delineation of novel 1p36 rearrangements by array-CGH analysis: narrowing the breakpoints and clarifying the "extended" phenotype.
Giannikou K; Fryssira H; Oikonomakis V; Syrmou A; Kosma K; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
Gene; 2012 Sep; 506(2):360-8. PubMed ID: 22766398
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of 50 patients reveals the critical chromosomal regions responsible for 1p36 deletion syndrome-related complications.
Shimada S; Shimojima K; Okamoto N; Sangu N; Hirasawa K; Matsuo M; Ikeuchi M; Shimakawa S; Shimizu K; Mizuno S; Kubota M; Adachi M; Saito Y; Tomiwa K; Haginoya K; Numabe H; Kako Y; Hayashi A; Sakamoto H; Hiraki Y; Minami K; Takemoto K; Watanabe K; Miura K; Chiyonobu T; Kumada T; Imai K; Maegaki Y; Nagata S; Kosaki K; Izumi T; Nagai T; Yamamoto T
Brain Dev; 2015 May; 37(5):515-26. PubMed ID: 25172301
[TBL] [Abstract][Full Text] [Related]
12. Tiling path resolution mapping of constitutional 1p36 deletions by array-CGH: contiguous gene deletion or "deletion with positional effect" syndrome?
Redon R; Rio M; Gregory SG; Cooper RA; Fiegler H; Sanlaville D; Banerjee R; Scott C; Carr P; Langford C; Cormier-Daire V; Munnich A; Carter NP; Colleaux L
J Med Genet; 2005 Feb; 42(2):166-71. PubMed ID: 15689456
[No Abstract] [Full Text] [Related]
13. Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions.
Yu W; Ballif BC; Kashork CD; Heilstedt HA; Howard LA; Cai WW; White LD; Liu W; Beaudet AL; Bejjani BA; Shaw CA; Shaffer LG
Hum Mol Genet; 2003 Sep; 12(17):2145-52. PubMed ID: 12915473
[TBL] [Abstract][Full Text] [Related]
14. Monosomy1p36.3 and trisomy 19p13.3 in a child with periventricular nodular heterotopia.
Descartes M; Mikhail FM; Franklin JC; McGrath TM; Bebin M
Pediatr Neurol; 2011 Oct; 45(4):274-8. PubMed ID: 21907895
[TBL] [Abstract][Full Text] [Related]
15. Monosomy 1p36 deletion syndrome.
Gajecka M; Mackay KL; Shaffer LG
Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):346-56. PubMed ID: 17918734
[TBL] [Abstract][Full Text] [Related]
16. Deletion in 1p36.33-p36.32 is associated with pancytopenia: a case report.
Yang H; Huang J; Zheng H; Zhang Y; Zhang Y; Liu W; Wu J; Chen X; Lin J; Ni Y; Nie X
BMC Med Genomics; 2023 Nov; 16(1):282. PubMed ID: 37946214
[TBL] [Abstract][Full Text] [Related]
17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
18. Cutis laxa in a patient with 1p36 deletion syndrome.
Zhang Z; Wang J; Li N; Yao R; Chen J
J Dermatol; 2018 Jul; 45(7):871-873. PubMed ID: 29611295
[TBL] [Abstract][Full Text] [Related]
19. Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome.
Heilstedt HA; Ballif BC; Howard LA; Lewis RA; Stal S; Kashork CD; Bacino CA; Shapira SK; Shaffer LG
Am J Hum Genet; 2003 May; 72(5):1200-12. PubMed ID: 12687501
[TBL] [Abstract][Full Text] [Related]
20. Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality.
Heilstedt HA; Ballif BC; Howard LA; Kashork CD; Shaffer LG
Clin Genet; 2003 Oct; 64(4):310-6. PubMed ID: 12974736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
